Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Invested Capital (2016 - 2025)

Historic Invested Capital for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $37.9 million.

  • Rockwell Medical's Invested Capital rose 2303.7% to $37.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.9 million, marking a year-over-year increase of 2303.7%. This contributed to the annual value of $34.1 million for FY2024, which is 4592.58% up from last year.
  • According to the latest figures from Q3 2025, Rockwell Medical's Invested Capital is $37.9 million, which was up 2303.7% from $31.6 million recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Invested Capital ranged from a high of $37.9 million in Q3 2025 and a low of -$1.8 million during Q1 2022
  • Its 5-year average for Invested Capital is $23.0 million, with a median of $23.3 million in 2022.
  • Its Invested Capital has fluctuated over the past 5 years, first plummeted by 10666.01% in 2022, then soared by 91919.3% in 2023.
  • Quarter analysis of 5 years shows Rockwell Medical's Invested Capital stood at $23.1 million in 2021, then rose by 0.74% to $23.3 million in 2022, then increased by 0.31% to $23.4 million in 2023, then surged by 45.93% to $34.1 million in 2024, then grew by 11.1% to $37.9 million in 2025.
  • Its Invested Capital was $37.9 million in Q3 2025, compared to $31.6 million in Q2 2025 and $32.9 million in Q1 2025.